Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 5/20 | 0.46 |
| ▸ | MAOB | P27338 | 5/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.42 |
| ▸ | PTGES | O14684 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15008984 | 1.00 | ALOX5 (0.47) | ALOX5BCHEMAOBKMT2ASMN1; SMN2 | |
| SCHEMBL15024186 | 1.00 | ALOX5 (0.47) | ALOX5BCHEMAOBKMT2ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL15008699 | 0.99 | ALOX5 (0.46) | ALOX5BCHEMAOBKMT2ASMN1; SMN2 | |
| SCHEMBL16871594 | 0.88 | BCHE (0.52) | ALOX5BCHEMAOBKMT2ASMN1; SMN2 | |
| SCHEMBL16871595 | 0.88 | BCHE (0.52) | ALOX5BCHEMAOBKMT2ASMN1; SMN2 | |
| SCHEMBL16871400 | 0.86 | BCHE (0.49) | ALOX5BCHEMAOBKMT2ASMN1; SMN2 | |
| SCHEMBL16871401 | 0.86 | BCHE (0.49) | ALOX5BCHEMAOBKMT2ASMN1; SMN2 | |
| SCHEMBL16871073 | 0.85 | BCHE (0.58) | ALOX5BCHEMAOBKMT2ASMN1; SMN2 | |
| SCHEMBL16871071 | 0.85 | BCHE (0.58) | ALOX5BCHEMAOBKMT2ASMN1; SMN2 | |
| SCHEMBL16871206 | 0.85 | KMT2A (0.49) | ALOX5BCHEMAOBKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150183727-A1 | METHOD FOR THE PREPARATION OF 1-ARYL-1-ALKYL-2-ALKYL-3-DIALKYLAMINOPROPANE COMPOUNDS | SIEGFRIED AG (CH) | 2015-07-02 | — | — | US | disclosed |
| US-20150183727-A1 | METHOD FOR THE PREPARATION OF 1-ARYL-1-ALKYL-2-ALKYL-3-DIALKYLAMINOPROPANE COMPOUNDS | SIEGFRIED AG (CH) | 2015-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150183727-A1 | METHOD FOR THE PREPARATION OF 1-ARYL-1-ALKYL-2-ALKYL-3-DIALKYLAMINOPROPANE COMPOUNDS | CYP3A43, CYP1A2, CYP2C8 | ALOX5 4068/4885BCHE 506/4885MAOB 801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.